5. Indications for glaucoma surgery
• Uncontrolled IOP or documented glaucomatous
progression in spite of maximum tolerated medical
therapy
4
Thursday, April 7, 2011
6. Indications for glaucoma surgery
• Uncontrolled IOP or documented glaucomatous
progression in spite of maximum tolerated medical
therapy
• Poor compliance with medical therapy
– Relative indication. Maximize compliance 1st
4
Thursday, April 7, 2011
7. Indications for glaucoma surgery
• Uncontrolled IOP or documented glaucomatous
progression in spite of maximum tolerated medical
therapy
• Poor compliance with medical therapy
– Relative indication. Maximize compliance 1st
• Pupillary block angle closure glaucoma
– Laser iridotomy 1st, then give medications if there is residual elevated IOP
4
Thursday, April 7, 2011
8. Indications for glaucoma surgery
• Uncontrolled IOP or documented glaucomatous
progression in spite of maximum tolerated medical
therapy
• Poor compliance with medical therapy
– Relative indication. Maximize compliance 1st
• Pupillary block angle closure glaucoma
– Laser iridotomy 1st, then give medications if there is residual elevated IOP
• Synechial angle closure for @ 360 degrees
– May go straight to trabeculectomy
4
Thursday, April 7, 2011
9. Indications for glaucoma surgery
• Uncontrolled IOP or documented glaucomatous
progression in spite of maximum tolerated medical
therapy
• Poor compliance with medical therapy
– Relative indication. Maximize compliance 1st
• Pupillary block angle closure glaucoma
– Laser iridotomy 1st, then give medications if there is residual elevated IOP
• Synechial angle closure for @ 360 degrees
– May go straight to trabeculectomy
• Congenital glaucoma
– Definitive treatment is surgery
4
Thursday, April 7, 2011
16. POAG PACG
Laser
Iridotomy
Medical Tx
Thursday, April 7, 2011
17. POAG PACG
Laser
Iridotomy
Medical Tx
Thursday, April 7, 2011
18. Secondary
POAG PACG
glaucoma
Laser
Iridotomy
Medical Tx
Thursday, April 7, 2011
19. Secondary
POAG PACG
glaucoma
Laser
Iridotomy
Medical Tx
Thursday, April 7, 2011
20. Secondary
POAG PACG
glaucoma
Laser
Treat primary Iridotomy
cause, if possible
Medical Tx
Thursday, April 7, 2011
21. Secondary
POAG PACG
glaucoma
Laser
Treat primary Iridotomy
cause, if possible
Medical Tx
Thursday, April 7, 2011
22. Secondary Congenital
POAG PACG glaucoma
glaucoma
Laser
Treat primary Iridotomy
cause, if possible
Medical Tx
Thursday, April 7, 2011
23. Secondary Congenital
POAG PACG glaucoma
glaucoma
Laser
Treat primary Iridotomy
cause, if possible
Medical Tx
Thursday, April 7, 2011
24. Secondary Congenital
POAG PACG glaucoma
glaucoma
Laser Refer to GL specialist:
Treat primary Iridotomy •Goniotomy, trabeculotomy,
cause, if possible
or combined trabeculotomy
+ trabeculectomy
Medical Tx
Thursday, April 7, 2011
25. Secondary Congenital
POAG PACG glaucoma
glaucoma
Laser Refer to GL specialist:
Treat primary Iridotomy •Goniotomy, trabeculotomy,
cause, if possible
or combined trabeculotomy
+ trabeculectomy
Medical Tx
Thursday, April 7, 2011
26. Secondary Congenital
POAG PACG glaucoma
glaucoma
Laser Refer to GL specialist:
Treat primary Iridotomy •Goniotomy, trabeculotomy,
cause, if possible
or combined trabeculotomy
+ trabeculectomy
Medical Tx
Thursday, April 7, 2011
27. Secondary Congenital
POAG PACG glaucoma
glaucoma
Laser Refer to GL specialist:
Treat primary Iridotomy •Goniotomy, trabeculotomy,
cause, if possible
or combined trabeculotomy
+ trabeculectomy
Medical Tx
No superior conjunctival
scarring, relatively
“quiet eye “; > 2y/o
Thursday, April 7, 2011
28. Secondary Congenital
POAG PACG glaucoma
glaucoma
Laser Refer to GL specialist:
Treat primary Iridotomy •Goniotomy, trabeculotomy,
cause, if possible
or combined trabeculotomy
+ trabeculectomy
Medical Tx
No superior conjunctival
scarring, relatively
“quiet eye “; > 2y/o
Thursday, April 7, 2011
29. Secondary Congenital
POAG PACG glaucoma
glaucoma
Laser Refer to GL specialist:
Treat primary Iridotomy •Goniotomy, trabeculotomy,
cause, if possible
or combined trabeculotomy
+ trabeculectomy
Medical Tx
No superior conjunctival
scarring, relatively
“quiet eye “; > 2y/o
Trabeculectomy
+ mitomycin-C
Thursday, April 7, 2011
30. Secondary Congenital
POAG PACG glaucoma
glaucoma
Laser Refer to GL specialist:
Treat primary Iridotomy •Goniotomy, trabeculotomy,
cause, if possible
or combined trabeculotomy
+ trabeculectomy
Medical Tx
No superior conjunctival
scarring, relatively
“quiet eye “; > 2y/o
Trabeculectomy
+ mitomycin-C
Thursday, April 7, 2011
31. Secondary Congenital
POAG PACG glaucoma
glaucoma
Laser Refer to GL specialist:
Treat primary Iridotomy •Goniotomy, trabeculotomy,
cause, if possible
or combined trabeculotomy
+ trabeculectomy
Medical Tx
No superior conjunctival •Any condition that has a high risk for
scarring, relatively failure for Trab w/ MMC
“quiet eye “; > 2y/o - scarred superior conjunctivae
- active proliferative membrane
in the AC (e.g. epithelial ingrowth, NV)
- active AC inflammation
- multiple failed trabeculectomies
Trabeculectomy
+ mitomycin-C
Thursday, April 7, 2011
32. Secondary Congenital
POAG PACG glaucoma
glaucoma
Laser Refer to GL specialist:
Treat primary Iridotomy •Goniotomy, trabeculotomy,
cause, if possible
or combined trabeculotomy
+ trabeculectomy
Medical Tx
No superior conjunctival •Any condition that has a high risk for
scarring, relatively failure for Trab w/ MMC
“quiet eye “; > 2y/o - scarred superior conjunctivae
- active proliferative membrane
in the AC (e.g. epithelial ingrowth, NV)
- active AC inflammation
- multiple failed trabeculectomies
Trabeculectomy
+ mitomycin-C
Thursday, April 7, 2011
33. Secondary Congenital
POAG PACG glaucoma
glaucoma
Laser Refer to GL specialist:
Treat primary Iridotomy •Goniotomy, trabeculotomy,
cause, if possible
or combined trabeculotomy
+ trabeculectomy
Medical Tx
No superior conjunctival •Any condition that has a high risk for
scarring, relatively failure for Trab w/ MMC
“quiet eye “; > 2y/o - scarred superior conjunctivae
- active proliferative membrane
in the AC (e.g. epithelial ingrowth, NV)
- active AC inflammation
- multiple failed trabeculectomies
Trabeculectomy
+ mitomycin-C
Thursday, April 7, 2011
34. Secondary Congenital
POAG PACG glaucoma
glaucoma
Laser Refer to GL specialist:
Treat primary Iridotomy •Goniotomy, trabeculotomy,
cause, if possible
or combined trabeculotomy
+ trabeculectomy
Medical Tx
No superior conjunctival •Any condition that has a high risk for
scarring, relatively failure for Trab w/ MMC
“quiet eye “; > 2y/o - scarred superior conjunctivae
- active proliferative membrane
in the AC (e.g. epithelial ingrowth, NV)
- active AC inflammation
- multiple failed trabeculectomies
Trabeculectomy
+ mitomycin-C
Glaucoma drainage device,
preferably by a GL specialist
Thursday, April 7, 2011
35. Secondary Congenital
POAG PACG glaucoma
glaucoma
Laser Refer to GL specialist:
Treat primary Iridotomy •Goniotomy, trabeculotomy,
cause, if possible
or combined trabeculotomy
+ trabeculectomy
Medical Tx
No superior conjunctival •Any condition that has a high risk for
scarring, relatively failure for Trab w/ MMC
“quiet eye “; > 2y/o - scarred superior conjunctivae Poor visual
- active proliferative membrane Potential
in the AC (e.g. epithelial ingrowth, NV) (LP-NLP)
- active AC inflammation
- multiple failed trabeculectomies
Trabeculectomy
+ mitomycin-C
Glaucoma drainage device,
preferably by a GL specialist
Thursday, April 7, 2011
36. Secondary Congenital
POAG PACG glaucoma
glaucoma
Laser Refer to GL specialist:
Treat primary Iridotomy •Goniotomy, trabeculotomy,
cause, if possible
or combined trabeculotomy
+ trabeculectomy
Medical Tx
No superior conjunctival •Any condition that has a high risk for
scarring, relatively failure for Trab w/ MMC
“quiet eye “; > 2y/o - scarred superior conjunctivae Poor visual
- active proliferative membrane Potential
in the AC (e.g. epithelial ingrowth, NV) (LP-NLP)
- active AC inflammation
- multiple failed trabeculectomies
Trabeculectomy
+ mitomycin-C
Glaucoma drainage device,
preferably by a GL specialist
Thursday, April 7, 2011
37. Secondary Congenital
POAG PACG glaucoma
glaucoma
Laser Refer to GL specialist:
Treat primary Iridotomy •Goniotomy, trabeculotomy,
cause, if possible
or combined trabeculotomy
+ trabeculectomy
Medical Tx
No superior conjunctival •Any condition that has a high risk for
scarring, relatively failure for Trab w/ MMC
“quiet eye “; > 2y/o - scarred superior conjunctivae Poor visual
- active proliferative membrane Potential
in the AC (e.g. epithelial ingrowth, NV) (LP-NLP)
- active AC inflammation
- multiple failed trabeculectomies
Trabeculectomy Consider
+ mitomycin-C transcleral
Glaucoma drainage device, cyclophoto-
coagulation if
preferably by a GL specialist w/ pain
Thursday, April 7, 2011
38. Secondary Congenital
POAG PACG glaucoma
glaucoma
Laser Refer to GL specialist:
Treat primary Iridotomy •Goniotomy, trabeculotomy,
cause, if possible
or combined trabeculotomy
+ trabeculectomy
Medical Tx
No superior conjunctival •Any condition that has a high risk for
scarring, relatively failure for Trab w/ MMC
“quiet eye “; > 2y/o - scarred superior conjunctivae Poor visual
- active proliferative membrane Potential
in the AC (e.g. epithelial ingrowth, NV) (LP-NLP)
- active AC inflammation
- multiple failed trabeculectomies
Trabeculectomy Consider
+ mitomycin-C transcleral
Glaucoma drainage device, cyclophoto-
coagulation if
preferably by a GL specialist w/ pain
Thursday, April 7, 2011
39. Secondary Congenital
POAG PACG glaucoma
glaucoma
Laser Refer to GL specialist:
Treat primary Iridotomy •Goniotomy, trabeculotomy,
cause, if possible
or combined trabeculotomy
+ trabeculectomy
Medical Tx
No superior conjunctival •Any condition that has a high risk for
scarring, relatively failure for Trab w/ MMC
“quiet eye “; > 2y/o - scarred superior conjunctivae Poor visual
- active proliferative membrane Potential
in the AC (e.g. epithelial ingrowth, NV) (LP-NLP)
- active AC inflammation
- multiple failed trabeculectomies
Trabeculectomy Consider
+ mitomycin-C transcleral
Glaucoma drainage device, cyclophoto-
coagulation if
preferably by a GL specialist w/ pain
Thursday, April 7, 2011
40. Secondary Congenital
POAG PACG glaucoma
glaucoma
Laser Refer to GL specialist:
Treat primary Iridotomy •Goniotomy, trabeculotomy,
cause, if possible
or combined trabeculotomy
+ trabeculectomy
Medical Tx
No superior conjunctival •Any condition that has a high risk for
scarring, relatively failure for Trab w/ MMC
“quiet eye “; > 2y/o - scarred superior conjunctivae Poor visual
- active proliferative membrane Potential
in the AC (e.g. epithelial ingrowth, NV) (LP-NLP)
- active AC inflammation
- multiple failed trabeculectomies
Trabeculectomy Consider
+ mitomycin-C transcleral
Glaucoma drainage device, cyclophoto-
coagulation if
Legend: preferably by a GL specialist w/ pain
Uncontrolled IOP
Thursday, April 7, 2011
43. Traction suture
Peripheral cornea Superior rectus
6
Thursday, April 7, 2011
44. Traction suture
• For good exposure of the surgical site
– Peripheral cornea
• Concerns:
– Perforation of the cornea
– Superior rectus
• Concerns:
– Greater potential for bleeding
– Risk of ptosis post-op
7
Thursday, April 7, 2011
46. Conjunctival Peritomy:
Fornix based
• Easier to create
• Easier exposure & dissection of the
sclera
• Creates a more posterior diffuse bleb
• May be more prone to leaks if not
closed properly
9
Thursday, April 7, 2011
52. Application of Anti-metabolites
• Mitomycin-C 2mg/ vial
– Concentration: 0.25 to 0.5 mg/ml
– Duration: 1 to 5 minutes
– Concentration & duration is dependent on the
appearance of the conjunctiva & presence of risk
factors for failure
14
Thursday, April 7, 2011
53. Application of Anti-metabolites
• Mitomycin-C 2mg/ vial
– Concentration: 0.25 to 0.5 mg/ml
– Duration: 1 to 5 minutes
– Concentration & duration is dependent on the
appearance of the conjunctiva & presence of risk
factors for failure
• 5-Fluorouracil 250mg/ml
– Intra-op: 0.5ml (25mg) to 1ml (50mg) for 5 mins
– Post-op: 0.1ml (5mg) subconjunctival injection
daily for 7-14 days (Total dose not to exceed 50mg
or 1ml.)
14
Thursday, April 7, 2011
65. Peripheral Iridectomy
• Iris usually prolapses through after
creation of the the limbal fistula
• Iridectomy should be wider than the
limbal fistula/ internal sclerectomy
• Better too wide than too small
26
Thursday, April 7, 2011
67. Scleral Flap closure
• 10-0 Nylon suture
• May use 2 to 6
interrupted sutures
• Burry all suture
knots
28
Thursday, April 7, 2011
68. Scleral Flap closure
• No standard number or tightness
of sutures
• Should be able to visualize
minimal aqueous flow through
the borders of the scleral flap
after AC reformation
– Add more sutures if there is
excessive aqueous flow
– Loosen or remove sutures if there
is no flow
• Better to err on the “tight side”
29
Thursday, April 7, 2011
69. Conjunctival Closure
Limbal based peritomy
JA Tumbocon, MD
30
Thursday, April 7, 2011
82. L a s e r Ir i d o to my
Thursday, April 7, 2011
83. Laser Iridotomy
• Mechanism
– Creates a bypass route for the aqueous to
flow from the posterior to the anterior
chamber & thus relieve relative or absolute
pupillary block
• Lasers
– Nd:YAG Laser
– Argon Laser
– Diode Laser
Thursday, April 7, 2011
84. Interruption of Pupillary block
• Creation of a hole in the outer
half of the iris (iridotomy /
iridectomy
– allows fluid from the PC to
enter to the AC, bypassing
the pupillary block
– equalization of pressure in
both chambers
– peripheral iris falls posteriorly
– opens the appositionally
closed angle
Thursday, April 7, 2011
86. Laser Iridotomy
• Other Indications:
– Nanophthalmos/ crowded “middle
segment”
– Prevent pseudophakic or aphakic pupillary
block
– With the use of post-vitrectomy silicone oil
(inferior iridectomy)
– Can be used as initial therapy in:
• Phacomorphic glaucoma
• Plateau iris
42
Thursday, April 7, 2011
87. Laser Iridotomy
Pre-op evaluation: Gonioscopy
Closed angles Opens on indentation
gonioscopy
43
Thursday, April 7, 2011
93. Nd: YAG Laser Iridotomy
• Suggested Settings:
– 2-6 mJ
– 1-4 pulses / burst
• Less bursts for phakic eyes
– 2-4 bursts
49
Thursday, April 7, 2011
94. Nd: YAG Laser Iridotomy
• Advantages:
– Fewer applications needed for
perforation
– Less inflammation
– Greater tendency to remain
patent
• Disadvantages:
– Possibility of bleeding from the
treatment site
50
Thursday, April 7, 2011
102. Argon Laser Iridotomy
• Advantage:
– Less potential for bleeding
• Disadvantage:
– Requires more energy and more prone to
closure than Nd:YAG iridotomy
55
Thursday, April 7, 2011
103. Combined Argon & Nd: YAG Laser
Iridotomy
• Suggested Settings:
– Argon: Use “chipping, drumhead or hump” technique
settings to thin out the iris.
– Nd:YAG for perforation: 1.5 - 5mJ, 1-2 pulses/burst,
1-2 bursts 56
Thursday, April 7, 2011
104. Combined Argon & Nd: YAG Laser
Iridotomy
• Suggested Settings:
– Argon: Use “chipping, drumhead or hump” technique
settings to thin out the iris.
– Nd:YAG for perforation: 1.5 - 5mJ, 1-2 pulses/burst,
1-2 bursts 56
Thursday, April 7, 2011
105. Laser Iridotomy
• Endpoint
– Rush of pigment bearing aqueous through
the iridectomy
– Deepening of the AC
– Presence of a retro-illuminated red reflex
(not definite sign of a patent iridotomy)
– Visualization of anterior lens capsule
through the iridectomy
57
Thursday, April 7, 2011
107. Laser Iridotomy
Pre-L.I. Post-L.I.
59
Thursday, April 7, 2011
108. Laser Iridotomy
• Immediate post-laser
– Check IOP hourly for at least 3 hours
(check for IOP spike)
– Topical steroids x 3-7 days
60
Thursday, April 7, 2011
110. Laser Iridotomy
• Post L.I. follow up
– Patency of iridotomy
– IOP
– Gonioscopy: Monitor the irido-corneal angle.
May still close in spite of a patent iridotomy
(possibly by other non-pupillary block mechanisms)
Long-term follow up is essential
62
Thursday, April 7, 2011